Clinical Trials
2 trialsNCT01707966 2019-05-15
Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy
Swiss Cancer Institute
Phase 3 Completed
NCT02053311 2018-07-30
Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents
Swiss Cancer Institute
Phase 3 Withdrawn